Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ASTRAZENECA PHARMA ZYDUS LIFESCIENCES/
ASTRAZENECA PHARMA
 
P/E (TTM) x 20.8 88.9 23.4% View Chart
P/BV x 2.5 16.1 15.4% View Chart
Dividend Yield % 0.6 0.3 197.1%  

Financials

 ZYDUS LIFESCIENCES   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
ASTRAZENECA PHARMA
Mar-22
ZYDUS LIFESCIENCES/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs6744,580 14.7%   
Low Rs3312,529 13.1%   
Sales per share (Unadj.) Rs149.1322.2 46.3%  
Earnings per share (Unadj.) Rs22.724.6 92.2%  
Cash flow per share (Unadj.) Rs29.731.4 94.5%  
Dividends per share (Unadj.) Rs2.5010.00 25.0%  
Avg Dividend yield %0.50.3 176.9%  
Book value per share (Unadj.) Rs166.1203.8 81.5%  
Shares outstanding (eoy) m1,023.7425.00 4,095.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.411.0 30.5%   
Avg P/E ratio x22.1144.3 15.3%  
P/CF ratio (eoy) x16.9113.1 15.0%  
Price / Book Value ratio x3.017.4 17.3%  
Dividend payout %11.040.6 27.1%   
Avg Mkt Cap Rs m514,27788,863 578.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,7772,302 946.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,6528,056 1,894.9%  
Other income Rs m2,354148 1,594.9%   
Total revenues Rs m155,0068,204 1,889.5%   
Gross profit Rs m34,427862 3,994.8%  
Depreciation Rs m7,130170 4,206.5%   
Interest Rs m1,27010 13,368.4%   
Profit before tax Rs m28,381830 3,417.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,117214 2,386.7%   
Profit after tax Rs m23,264616 3,776.6%  
Gross profit margin %22.610.7 210.8%  
Effective tax rate %18.025.8 69.8%   
Net profit margin %15.27.6 199.3%  
BALANCE SHEET DATA
Current assets Rs m122,6147,653 1,602.1%   
Current liabilities Rs m78,3943,923 1,998.3%   
Net working cap to sales %29.046.3 62.6%  
Current ratio x1.62.0 80.2%  
Inventory Days Days9361 151.2%  
Debtors Days Days8039 205.2%  
Net fixed assets Rs m144,3822,120 6,810.5%   
Share capital Rs m1,02450 2,048.0%   
"Free" reserves Rs m168,9725,044 3,349.7%   
Net worth Rs m169,9965,094 3,336.9%   
Long term debt Rs m3,6210-   
Total assets Rs m266,9969,773 2,731.9%  
Interest coverage x23.388.4 26.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 69.4%   
Return on assets %9.26.4 143.6%  
Return on equity %13.712.1 113.2%  
Return on capital %17.116.5 103.6%  
Exports to sales %00-   
Imports to sales %14.331.7 45.2%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m21,8692,552 856.9%   
Fx inflow Rs m63,065442 14,268.1%   
Fx outflow Rs m21,8692,552 856.9%   
Net fx Rs m41,196-2,110 -1,952.4%   
CASH FLOW
From Operations Rs m21,0411,008 2,087.4%  
From Investments Rs m11,54447 24,354.4%  
From Financial Activity Rs m-8,683-95 9,178.6%  
Net Cashflow Rs m23,729961 2,469.7%  

Share Holding

Indian Promoters % 75.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.5 3.8 407.6%  
FIIs % 2.6 2.5 104.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.1%  
Shareholders   408,231 49,085 831.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Cadila Healthcare vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs ASTRAZENECA PHARMA Share Price Performance

Period Cadila Healthcare ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 1.03% -1.56% -0.10%
1-Month -4.82% -3.79% -1.99%
1-Year -9.74% 5.50% -5.62%
3-Year CAGR 17.20% 5.18% 20.96%
5-Year CAGR -0.41% 24.13% 11.47%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

ASTRAZENECA PHARMA paid Rs 10.0, and its dividend payout ratio stood at 40.6%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.